For the quarter ending 2025-09-30, ETON has $104,510K in assets. $81,384K in debts. $37,121K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalent | 37,121 | 25,379 | ||
| Accounts receivable, net | 13,082 | 14,453 | ||
| Inventories, net | 16,855 | 23,791 | ||
| Prepaid expenses and other current assets | 4,942 | 4,820 | ||
| Total current assets | 72,000 | 68,443 | ||
| Property and equipment, net | 294 | 18 | ||
| Intangible assets, net | 31,878 | 32,879 | ||
| Operating lease right-of-use assets, net | 319 | 324 | ||
| Other long-term assets, net | 19 | 12 | ||
| Total assets | 104,510 | 101,676 | ||
| Accounts payable | 14,259 | 12,142 | ||
| Short-term debt, net of discount | 2,776 | 2,769 | ||
| Accrued medicaid rebates | 18,031 | 16,226 | ||
| Accrued liabilities | 9,117 | 7,459 | ||
| Total current liabilities | 44,183 | 38,596 | ||
| Long-term debt, net of current portion, debt discount and accrued exit fees | 27,591 | 27,409 | ||
| Operating lease liabilities, noncurrent | 480 | 492 | ||
| Long-term inventory payable | 5,188 | 6,949 | ||
| Other long-term liabilities | 3,942 | 4,269 | ||
| Total liabilities | 81,384 | 77,715 | ||
| Common stock, 0.001 par value 50,000,000 shares authorized 26,817,535 and 26,709,084 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 27 | 27 | ||
| Additional paid-in capital | 137,076 | 135,984 | ||
| Accumulated deficit | -113,977 | -112,050 | ||
| Total stockholders equity | 23,126 | 23,961 | ||
| Total liabilities and stockholders equity | 104,510 | 101,676 | ||
Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON)